Nathalie Massicotte, MD, FRCPC
Centre hospitalier de l'Université de Montréal (CHUM)
5
5
5
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
Joaquim MATEO, MD
Assistance Publique - Hôpitaux de Paris
Shared therapeutic areas:
sanqing Jin, MD
Sixth Affiliated Hospital, Sun Yat-sen University
Shared therapeutic areas:
Martin Petzoldt, MD
Universitätsklinikum Hamburg-Eppendorf
Shared therapeutic areas:
Marc Fischler, MD
Hôpital Foch
Shared therapeutic areas:
Daniel i Sessler, MD
The Cleveland Clinic
Shared therapeutic areas:
In Kyong Yi, MD
Ajou University School of Medicine
Shared therapeutic areas:
Marc Fischler, MD
Hopital Foch
Shared therapeutic areas:
Jin-Tae Kim, PhD
Seoul National University Hospital
Shared therapeutic areas:
Nicolai Goettel, MD
University Hospital, Basel, Switzerland
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Comparison of LMA-Fastrach and I-gel for Blind Tracheal Intubation.
Partial Thromboplastin Time During the First 24 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin (UFH)
Does the Use of the GlideRite® Endotracheal Tube in Combination With the I-gel® Improve Intubation Success Rate?
Efficacy of Two Bolus Doses of Remifentanil on the Incidence of Coughing During Emergence of Anesthesia
Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin
All 5 trials loaded